Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes
NCT ID: NCT00928616
Last Updated: 2009-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2009-04-30
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Effects of Plant Sterol and Stanol Esters
NCT00802516
Phytosterols and Oxyphytosterol Concentrations
NCT01559428
Plant Sterols and Plant Stanols and Liver Inflammation
NCT03627819
Effect of Plant Stanol Esters on Blood Lipids
NCT00920894
Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)
NCT06481020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
plant sterol esters
Participants consume plant sterol ester supplemented margarine (3 g/day)
margarine + plant sterol esters
margarine supplemented with plant sterol esters (3g/day) over the time period of 4 weeks
Placebo
Placebo is a non-sterol ester supplemented margarine
margarine (placebo)
non-sterol ester supplemented margarine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
margarine + plant sterol esters
margarine supplemented with plant sterol esters (3g/day) over the time period of 4 weeks
margarine (placebo)
non-sterol ester supplemented margarine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* other use of dietary supplements
* vegetarianism
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Saarland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of the Saarland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Weingärtner, MD
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III
Homburg, Saarland, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
108/07
Identifier Type: -
Identifier Source: secondary_id
108/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.